Merck announces ZIOPTAN™ (tafluprost ophthalmic solution) 0.0015%

Special Savings Offers

Multiuse MyAccess Card

Eligible patients whose commercial or Medicare Part D or Medicare Advantage prescription drug plan does not cover ZIOPTAN may pay $49 for each 30-day qualifying prescription of ZIOPTAN in 2013
(for up to 10 prescriptions). Certain restrictions apply. Please see Terms and Conditions.

Multiuse 50%
Off Savings Coupon

Eligible patients with commercial insurance or who are uninsured may save 50% off of their out-of-pocket cost on each of up to 12 qualifying prescriptions. Maximum savings is $75 per prescription. Certain restrictions apply. Please see Terms and Conditions.

Sign up to get the latest updates and e-mail alerts about ZIOPTAN™ (tafluprost ophthalmic solution) 0.0015%.

Please enter the following information to receive additional information about ZIOPTAN.

Items marked with an * are required.

Merck's Privacy Commitment

The information you provided will be available to the Merck & Co., Inc., family of companies (collectively, "Merck") and others working on behalf of Merck, and according to the same standards, to provide the information and services you request. Personal information about you will not otherwise be disclosed for marketing purposes without your permission. Merck reviews personal information and nonidentifiable information not only to provide the requested information and services but also to develop and offer additional services and communications that we believe our customers might find of interest. Merck also may use personal information to audit its resources for compliance and security purposes. For more information about how Merck protects personal information about you, please read the Internet Privacy Policy and the Privacy Statement for patients, consumers, and caregivers.

*First Name: *Last Name: *E-mail Address: *Date of Birth:

*Address 1: Address 2: *City: *State: *ZIP Code:

By providing your name, address, and other personal information, and by clicking the "submit" button below, you agree to permit Merck, and others working on behalf of Merck, to use this information to provide the information about ZIOPTAN that you have requested.

Occasionally, Merck sends e-mail and other communications about new resources or services related to ZIOPTAN. Please check the box below this paragraph if you would like to receive additional information in the future about ZIOPTAN. Also, at any time, you can request a copy of your selections on this form and that personal information about you be removed from the Merck contact list for ZIOPTAN by calling 1-888-776-8364.

I wish to receive additional information about ZIOPTAN in the future. I understand that unless I change my selection sooner, my permission will expire 1 year after Merck no longer promotes ZIOPTAN.

Merck, and others working on behalf of Merck, may provide additional materials about other Merck products and services, health conditions, and topics that Merck believes you might find useful. You also may be asked for your opinion about programs and materials. By checking the box below, you agree to receive additional information and to be contacted about other Merck products and services, health conditions, and topics in the future. At any time, you can request that personal information about you be removed from the Merck contact list for additional materials and services by calling 1-888-776-8364.

I wish to receive this additional information and to be contacted in the future. I understand that unless I change my selection sooner, my permission will expire 1 year after Merck no longer promotes ZIOPTAN.

By clicking "submit" I am signing this form. I agree that my information may be used as described above, as well as for market research purposes.